Efficacy and safety of the dual GIP and GLP-1 receptor agonist tirzepatide for weight loss: a meta-analysis of randomized controlled trials
And that number appears to be rising as drug makers develop new versions, including oral medicines in place of injections and products approved for different diseases
To some people, yesthough others barely feel anything at all
These steps not only reduce discomfort but also improve the effectiveness of the medication
Published literature describes investigations into pathways such as angiogenesis, the nitric oxide (NO) system, and tissue repair signaling in rodent models (Sikiric et al., 2025, Pharmaceuticals)
Its use is considered illegal in many countries, and it is often sold on the gray market, where product quality and purity are not guaranteed, posing additional health risks